Orexo submits New Drug Application for fentanyl overdose

 

• OX124 is designed to reverse the effects of the most powerful synthetic opioids, such as fentanyl
• Nine out of ten fatal opioid overdoses in the US involve synthetic opioids
• If approved, the US launch is expected to be initiated in H1 2024

https://www.biospace.com/article/releases/orexo-submits-new-drug-application-to-fda-for-ox124-a-high-dose-rescue-medication-for-opioid-overdose/